Corvus Pharmaceuticals EV to Revenues Analysis

Corvus Pharmaceuticals Inc (CRVS)

5.00 -0.09 (-1.77%) USD | NASDAQ | Dec 20, 16:00

4.83 -0.17 (-3.40%) After-Hours: 05:16

View EV to Revenues for CRVS.
Upgrade now.

Sep '18

Jan '19

May '19

285.00

270.00

255.00

240.00

View EV to Revenues Chart

Start Trial

View Historical Data

Start Trial

View EV to Revenues Range, Past 5 Years

Start Trial

Minimum

Maximum

Average

Median

View EV to Revenues Benchmarks

Start Trial

Perspective Therapeutics Inc	Upgrade
Sarepta Therapeutics Inc	Upgrade
Cara Therapeutics Inc	Upgrade
Atara Biotherapeutics Inc	Upgrade
Clearside Biomedical Inc	Upgrade

Upgrade